HROW Harrow Health, Inc.

Harrow Health, Inc. (formerly Imprimis Pharmaceuticals Inc) is engaged in the development, production and sale of medications that offer competitive advantages and serve unmet needs. The company intends to deliver high-quality medications to physicians and patients.

$21.22  +2.80 (15.20%)
As of 03/27/2023 14:15:17 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2019
Outstanding shares:  27,074,307
Average volume:  370,367
Market cap:   $467,031,796
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BHNDW86

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%